Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
718 |
|
| Actual shortage: | 20 (3%) | |
| Anticipated shortage: | 6 (1%) | |
| Avoided shortage: | 88 (12%) | |
| Resolved: | 604 (84%) | |
Discontinuation Reports |
235 |
|
| To be discontinued: | 0 (0%) | |
| Discontinued: | 235 (100%) | |
| Reversed: | 0 (0%) | |
Late reports |
89 (9%) |
|
Overdue reports |
19 (73%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Avoided shortage | 2020-10-14 | 2020-10-20 | 126325 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-01-10 | 2023-03-20 | 180346 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-06-21 | 2023-08-16 | 196061 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2023-08-16 | 2023-11-06 | 201965 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Resolved | 2024-09-24 | 2024-12-16 | 238425 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Avoided shortage | 2025-01-28 | 2025-03-04 | 248755 |
| MYLAN-HYDROXYUREA | 500MG | CAPSULE | Anticipated shortage | 2025-03-04 | 2025-04-28 | 251917 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2021-11-17 | 2021-12-21 | 149495 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-01-18 | 2022-01-26 | 152983 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Avoided shortage | 2022-02-02 | 2022-02-25 | 154043 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2022-02-23 | 2022-03-10 | 155442 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2022-09-01 | 2022-09-07 | 168381 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2023-06-27 | 2023-11-14 | 196701 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2024-06-11 | 2024-07-09 | 230100 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2024-07-09 | 2024-10-29 | 232575 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2024-11-18 | 2025-01-07 | 243383 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2019-01-18 | 189 |
| MYLAN-INDAPAMIDE | 1.25MG | TABLET | Resolved | 2017-03-10 | 2017-03-15 | 191 |
| MYLAN-INDAPAMIDE | 2.5mg | Tablet | Resolved | 2017-03-10 | 2017-03-31 | 194 |
| MYLAN-INDAPAMIDE | 2.5MG | TABLET | Resolved | 2017-03-23 | 2017-04-04 | 4073 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| MYLAN-VALSARTAN HCTZ | 25MG 320MG | TABLET | Discontinued | 2017-04-13 | 2017-04-13 | 6845 |
| MYLAN-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20259 |
| MYLAN-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-02-15 | 20287 |
| MYLAN-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2017-08-24 | 2018-07-04 | 20306 |
| MYLAN-VERAPAMIL | 80MG | TABLET | Discontinued | 2024-04-11 | 2024-04-12 | 224846 |
| MYLAN-ZOLMITRIPTAN | 2.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51647 |
| MYLAN-ZOLMITRIPTAN ODT | 2.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2018-06-06 | 2018-07-04 | 51653 |
| MYLAN-ZOPICLONE | 5MG | TABLET | Discontinued | 2018-05-04 | 2018-05-04 | 48576 |
| MYLAN-ZOPICLONE | 7.5MG | TABLET | Discontinued | 2018-06-06 | 2018-07-04 | 51665 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160318 |
| ONDANSETRON INJECTION, USP | 2MG | SOLUTION | Discontinued | 2022-05-11 | 2022-05-11 | 160323 |
| TOBRAMYCIN INJECTION, USP | 40MG | SOLUTION | Discontinued | 2022-01-12 | 2022-01-12 | 152485 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 500MG | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51668 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 1G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51671 |
| VANCOMYCIN HYDROCHLORIDE FOR INJECTION, USP | 5G | POWDER FOR SOLUTION | Discontinued | 2018-06-06 | 2018-06-08 | 51674 |